Alzheimer's Drugs May Be a Big-Pharma Payday. Lilly and Biogen Are Facing Off. barrons.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from barrons.com Daily Mail and Mail on Sunday newspapers.
With U.S. approval of Eisai's and Biogen's Alzheimer's drug Leqembi secured, Wall Street analysts said they expect other region's health regulators to follow suit even if they share similar concerns about a potentially severe side effect.
By Bhanvi Satija (Reuters) - With U.S. approval of Eisai s and Biogen s Alzheimer s drug Leqembi secured, Wall Street analysts said they expect other .